With three dynamic tracks covering discovery, preclinical, clinical, and CMC, plus exclusive seminar days on ADC fundamentals and Bispecific ADCs, this guide ensures you gain critical insights and ...
SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE)-- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, ...
ArriVent Biopharma, a company that secures rights to drugs from emerging markets to develop them for Western markets, is adding to its pipeline with a Phase 1-ready drug candidate from China that has ...
When lung cancer advances after initial lines of therapy, the treatment options dwindle. An AbbVie drug gives patients a new choice as the first FDA-approved treatment for advanced cases of non-small ...
LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE: ADCT), a late clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results